Cade

Blackford and Bot Image Announce Partnership to Enhance Prostate Cancer Care

Retrieved on: 
Tuesday, January 16, 2024
Entrepreneurship, Patient, MRI, Prostate cancer, Bot, Partnership, Radiology, Google Images, AI, Cancer, Cade, Physician, Medical imaging

EDINBURGH, Scotland, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Blackford, the pioneering AI platform and solutions provider, and Bot Image today announced a commercial partnership to bring Bot Image’s ProstatID solution to healthcare professionals via the Blackford Platform.

Key Points: 
  • EDINBURGH, Scotland, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Blackford, the pioneering AI platform and solutions provider, and Bot Image today announced a commercial partnership to bring Bot Image’s ProstatID solution to healthcare professionals via the Blackford Platform.
  • Under the partnership, Bot Image's innovative technology will be integrated with Blackford's enterprise AI platform.
  • By integrating Bot Image’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers powerful tools for detection of prostate cancer on MR scans.
  • "We’re delighted to partner with Bot Image and to add their ProstatID solution to our extensive AI portfolio,” said Ben Panter, Founder and CEO of Blackford.

Iterative Health Presents Award-Winning Research on the Benefits of Gastroenterological Technology at the American College of Gastroenterology Annual Scientific Meeting

Retrieved on: 
Monday, October 23, 2023
Technology, Surgery, Medical Devices, Medical Supplies, Clinical Trials, Other Health, Health, General Health, Artificial Intelligence, GI, FDA, Intelligence, American College, Harvard Medical School, Crohn's disease, MPH, Outline of health sciences, Adenoma, Use, ACG, Prevalence, Rutgers University–New Brunswick, Cade, Publication, Doctor of Philosophy, MBA, American College of Gastroenterology, Research, Computer science, Computer-aided, George Washington University School of Medicine & Health Sciences, Artificial intelligence, APC, Colonoscopy, School, University of North Dakota, CRC, Clinical trial, Abstract, University, Medical diagnosis, Mount Auburn Hospital, Safety, Boston Medical Center, Inflammatory bowel disease, MS, Medical imaging, Management, Medical device, Gastroenterology, MD, Colitis, Geriatrics, Medicine

Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting.

Key Points: 
  • Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting.
  • This research represents strides toward enhancing the detection of precursor adenomas and streamlining clinical trial recruitment processes in gastroenterology, ultimately bringing us closer to a future of advancing patient care in the field.
  • The publications include:
    Authors: William Holderman, MD; Parth Jain; Mitchell Reddan, MS; Haig Soghigian, MBA; Christopher Fourment, MD.
  • To learn more about Iterative Health, please visit iterative.health .

National Cade Prize for Innovation Names 21 Finalists

Retrieved on: 
Tuesday, August 22, 2023
Agriculture, Natural Resources, Other Manufacturing, Environment, Destinations, Travel, Recycling, Manufacturing, Arts, Museums, Other Health, Entertainment, Other Technology, Other Philanthropy, Other Energy, Other Science, Energy, Other Education, Technology, General Entertainment, Education, Security, Satellite, Science, Sustainability, Health, Philanthropy, Green Technology, National Inventors Hall of Fame, Florida Trend, Private sector, Plastic, Private law, Engineering, Consultant, Cade, Cade Museum for Creativity and Invention, Florida Power & Light, Innovation, Research, COVID, Creativity, Wind, Patient, Ammonia, FPL, Invention, Pet, Biophysical environment, Digital, Auction, Medical device, Medical imaging, Road, Information technology

Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci Finalists.

Key Points: 
  • Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci Finalists.
  • For the first time, this year’s 14th Annual Cade Prize for Innovation accepted applications from inventors and entrepreneurs based anywhere in the United States.
  • “We were very pleased to see strong interest in the Cade Prize from leading research institutions across the country,” said Cade co-founder Richard Miles.
  • The Cade Prize, a capstone initiative of the Cade Museum for Creativity and Invention , is named after Dr. James Robert Cade, Gatorade’s lead inventor.

Blackford and Lunit Inc announce partnership to enhance chest and breast AI solution offering

Retrieved on: 
Thursday, July 27, 2023
Partnership, INSIGHT, Cancer, Pathology, Radiology, Blackford, Patient, Physician, Algorithm, X-ray, Triage, MMG, Cade, Medical device, Medical imaging, AI

EDINBURGH, Scotland, July 27, 2023 (GLOBE NEWSWIRE) -- Blackford, the pioneering strategic imaging AI platform and solutions provider, and Lunit Inc, a chest Xray and mammography AI provider announce a partnership to make Lunit INSIGHT CXR, INSIGHT CXR Triage and INSIGHT MMG available on the Blackford Platform.

Key Points: 
  • EDINBURGH, Scotland, July 27, 2023 (GLOBE NEWSWIRE) -- Blackford, the pioneering strategic imaging AI platform and solutions provider, and Lunit Inc, a chest Xray and mammography AI provider announce a partnership to make Lunit INSIGHT CXR, INSIGHT CXR Triage and INSIGHT MMG available on the Blackford Platform.
  • Lunit’s AI applications will enable Blackford customers to detect cancer on chest radiographs and mammograms.
  • "Blackford is committed to delivering AI applications that broaden clinical and operational AI use cases and drive additional value for healthcare organizations and their patients,” said Blackford CEO Ben Panter.
  • "Driven by our commitment to advancing medical AI, Lunit is continuously expanding its application of AI solutions for the early detection of diseases," said Brandon Suh, CEO of Lunit.

Medtronic Recognized for Artificial Intelligence Innovation in 2023 AI Breakthrough Awards Program

Retrieved on: 
Wednesday, June 21, 2023
Natural language processing, Artificial Intelligence for IT Operations, Deep learning, Synthetic media, Eye, Cancer, Intelligence, Gastroenterology, Large intestine, Endoscopy, Computer vision, Colorectal cancer, Death, Data, Physician, Polyp (medicine), Machine learning, Algorithm, Robotics, Generative, Colonoscopy, Artificial intelligence, AI, FDA, GI, Cade, Polyp, Software, Medical device, Mobile phone, Medtronic

LOS ANGELES, June 21, 2023 /PRNewswire-PRWeb/ -- AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Medtronic plc, the leading global healthcare technology company, has been selected as winner of the "Best Deep Learning Platform" award in the sixth annual AI Breakthrough Awards program, recognizing the breakthrough innovation of Medtronic's GI Genius™ system.

Key Points: 
  • LOS ANGELES, June 21, 2023 /PRNewswire-PRWeb/ -- AI Breakthrough , a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Medtronic plc , the leading global healthcare technology company, has been selected as winner of the "Best Deep Learning Platform" award in the sixth annual AI Breakthrough Awards program, recognizing the breakthrough innovation of Medtronic's GI Genius™ system.
  • GI Genius is the first FDA authorized computer-aided detection (CADe) system using AI to help endoscopists identify colorectal polyps, regardless of shape, size, or morphology.
  • Our expanding AI capabilities at Medtronic create opportunities to deliver against unmet needs, including across the Gastrointestinal (GI) practice."
  • However, colonoscopy is difficult, and polyps may be difficult to find," said James Johnson, managing director, AI Breakthrough.

Applications Open Today for 14th Annual Cade Prize!

Retrieved on: 
Wednesday, May 31, 2023
Agriculture, Natural Resources, Other Manufacturing, Environment, Entrepreneur, Recycling, Manufacturing, Arts, Museums, Other Health, Entertainment, Other Technology, Other Philanthropy, Other Energy, Other Science, Energy, Other Education, University, Technology, Education, Security, Satellite, Science, Sustainability, Health, Philanthropy, Consumer, Green Technology, National Inventors Hall of Fame, Cade, Cade Museum for Creativity and Invention, Innovation, Journal of Agricultural and Environmental Ethics, Creativity, Invention, Biophysical environment, Wild card, Wool, Health care, Tech

For the first time, the Cade Museum for Creativity and Invention welcomes inventors and entrepreneurs based anywhere in the United States to apply for its 14th Annual Cade Prize for Innovation competition from May 31 to July 31, 2023.

Key Points: 
  • For the first time, the Cade Museum for Creativity and Invention welcomes inventors and entrepreneurs based anywhere in the United States to apply for its 14th Annual Cade Prize for Innovation competition from May 31 to July 31, 2023.
  • Along with its national expansion in 2023, the Cade Prize has increased its prize purse from $64,000 to $100,000 to provide winners with more capital to move their invention into the marketplace.
  • The Cade Prize is unique in that it awards innovation at its earliest stages – no prototype necessary!
  • Cade Prize Awards Ceremony and Grand Prize Winner Announced: September 28, 2023, at the Cade Museum in Gainesville, Florida.

Henry Schein One Announces Availability of AI Solutions for Dentrix Ascend

Retrieved on: 
Monday, March 20, 2023
Software, Radiology, Medical Supplies, Health, Artificial Intelligence, Medical Devices, Technology, Dental, X-ray, Internet Brands, Workflow, Voice recognition, Multimedia, Human voice, Henry Schein, Dentist, Trust, Patient, Henry, Artificial intelligence, AI, FDA, Cade, Medical device, Dentrix

Henry Schein One, a joint venture of Henry Schein Inc. and Internet Brands, has reinforced their commitment to helping dental practices harness the power of Artificial Intelligence (AI) by fully integrating AI solutions into Dentrix Ascend, the Company’s cloud-based practice management software.

Key Points: 
  • Henry Schein One, a joint venture of Henry Schein Inc. and Internet Brands, has reinforced their commitment to helping dental practices harness the power of Artificial Intelligence (AI) by fully integrating AI solutions into Dentrix Ascend, the Company’s cloud-based practice management software.
  • These solutions include Dentrix® Ascend Detect AI powered and manufactured by VideaHealth, and Dentrix Ascend Voice, powered by Bola AI.
  • View the full release here: https://www.businesswire.com/news/home/20230318005075/en/
    Both Dentrix Ascend Detect AI and Dentrix Ascend Voice offer powerful tools to help dental professionals improve case acceptance and elevate patient care through accurate diagnoses.
  • “We’re excited to now bring our AI enabled X-ray analysis and voice recognition solutions to our Dentrix Ascend customers, and we’ll continue to invest in AI solutions that can help dentists provide the best possible patient care.”
    To learn more about Dentrix Ascend Detect AI and Dentrix Ascend Voice, please visit https://www.dentrixascend.com/apps/ascend-detect-ai and https://www.dentrixascend.com/apps/voice .

Henry Schein Announces Lineup of New Products, Software, and Equipment at the Chicago Dental Society Midwinter Meeting

Retrieved on: 
Monday, February 20, 2023
Technology, Audio, Video, Health, Other Health, Radiology, Artificial Intelligence, Practice Management, Medical Devices, Software, Health Technology, Hardware, Health Insurance, Dental, Medical Supplies, Emerald, CMW, Laser, Workflow, Digital technology, Schick, Artificial intelligence, DCI, American Dental Society of Anesthesiology, Cade, AI, Marketing, FDA, Practice management, DTX, Unitas, Dentistry, Medical device, Effects of meditation, Planmeca, Dentrix

Dental Group, Henry Schein.

Key Points: 
  • Dental Group, Henry Schein.
  • “The meeting is an opportunity for Henry Schein to demonstrate how we can help enhance the customer experience.
  • Created with the digital workflow in mind, the sensors also connect easily into existing digital systems within the dental practice.
  • To learn more about Henry Schein’s presence at this year’s CMW, please visit https://henryscheinevents.com/ .

Imagen Technologies Announces FDA Clearance of Aorta-CAD

Retrieved on: 
Monday, December 5, 2022
Nouvelle AI, Physician, Diagnosis, Food, Conditional sentence, PCP, Cade, Patient, FDA, Deep learning, Aorta, Quality of life, Primary care, Data as a service, Multimedia, Clinical trial, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Radiology, PACS, Medical device, Medical imaging, Medicine, Imagen

NEW YORK , Dec. 5, 2022 /PRNewswire/ -- Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the computer-assisted detection (CADe) device Aorta-CAD. This new, FDA cleared device is designed to assist physicians at detecting findings on chest X-rays that are suggestive of Aortic Atherosclerosis and Aortic Ectasia.

Key Points: 
  • NEW YORK, Dec. 5, 2022 /PRNewswire/ -- Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the computer-assisted detection (CADe) device Aorta-CAD .
  • This new, FDA cleared device is designed to assist physicians at detecting findings on chest X-rays that are suggestive of Aortic Atherosclerosis and Aortic Ectasia.
  • This FDA clearance, Imagen's 4th, marks another major milestone for the company as it seeks to improve patient outcomes by making frontline imaging diagnostics suitable for PCP offices.
  • About Imagen Technologies, Inc. Imagen's mission is to improve the accessibility, accuracy, and immediacy of frontline diagnostic imaging.

Henry Schein One Partners With VideaHealth to Launch New Dentrix Detect AI X-Ray Analysis Tool to Enhance Patient Care

Retrieved on: 
Tuesday, November 29, 2022
Medical Devices, Health, Technology, Health Technology, Other Health, Artificial Intelligence, Pillar, Software, Multimedia, Axium, Artificial intelligence, Health, Partnership, Patient, Cade, Henry Schein, Inc. v. Archer & White Sales, Inc., S&P, Government, Dentist, Harvard University, MIT, Radioactive decay, Infomed, Dentistry, Supply chain, Research, Intelligence, DSOS, Spark Capital, Internet Brands, Medical device, Medical imaging, Dentrix

As a result, Henry Schein One is introducing Dentrix Detect AI powered and manufactured by VideaHealth, an AI-enabled X-Ray analysis tool that integrates directly into Dentrix Practice Management Systems.

Key Points: 
  • As a result, Henry Schein One is introducing Dentrix Detect AI powered and manufactured by VideaHealth, an AI-enabled X-Ray analysis tool that integrates directly into Dentrix Practice Management Systems.
  • View the full release here: https://www.businesswire.com/news/home/20221128005861/en/
    Dentrix Detect AI is an AI-enabled X-ray analysis tool that provides real-time clinical decision support to dentists.
  • Together with VideaHealth, we look forward to helping dental professionals further elevate the digitalization of patient care through AI.
  • Henry Schein One selected VideaHealth for its diagnostic AI capabilities based on the accuracy of its dental pathology detection solution, patient experience, and the platforms ease of use.